⑴ Official in charge of disbursement of the procuring entity : Hideyuki Yoshizumi, Director, National Hospital Organization, Miyakonojo Medical Center

⑵ Classification of the products to be procured : 4

⑶ Nature and quantity of the products to be purchased,

HEMLIBRA for Subcutaneous Injection 90mg Qty : 56

ULTOMIRIS for Intravenous Infusion 300mg Qty : 70

⑷ Delivery period : From August 1, 2021 to September 30, 2022

⑸ Delivery place : National Hospital Organization, Miyakonojo Medical Center

⑹ Qualification for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :

① not come under Article 5 of the Regulation concerning Contract for National Hospital Organization (NHO). Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause ;

② not come under Article 6 of the Regulation concerning Contract for NHO ;

③ have Grade A, B or C in "Sales of products" for participating in tenders by Ministry of Health, Labour and Welfare (Single qualification for every ministry and agency) in Kyushu-Okinawa Region ;

④ prove to have obtained the firstclass license for selling drugs in accordance with the Pharmaceutical Affairs Law ;

⑤ prove that they can deliver the drugs on the date and to the place specified by the Obligating Officer ;

⑥ meet the qualification requirements which the Obligating Officer may specify in accordance with Article 4 of the Regulation ;

⑺ Time-limit for tender : 5 : 00 P.M. July 5, 2021

⑻ Contact point for the notice : Teruhiko Kamenosono, Director, Accounting Division, National Hospital Organization, Miyakonojo Medical Center, 5033-1 Iwayoshi-cho Miyakonojo-shi Miyazaki-

ken, 885-0014, Japan. TEL0986-23-4111